Cross-National Evidence on Generic Pharmaceuticals : Pharmacy vs. Physician-Driven Markets
Year of publication: |
2011
|
---|---|
Authors: | Danzon, Patricia M. |
Other Persons: | Furukawa, Michael (contributor) |
Publisher: |
[2011]: [S.l.] : SSRN |
Subject: | Pharmaindustrie | Pharmaceutical industry | Generika | Generic drugs | Wettbewerb | Competition | Regulierung | Regulation | OECD-Staaten | OECD countries | Gesundheitskosten | Health care costs | Patentrecht | Patent law |
Extent: | 1 Online-Ressource (44 p) |
---|---|
Series: | NBER Working Paper ; No. w17226 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments July 2011 erstellt |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Cross-national evidence on generic pharmaceuticals : pharmacy vs. physician-driven markets
Danzon, Patricia Munch, (2011)
-
Cross-National Evidence on Generic Pharmaceuticals : Pharmacy vs. Physician-Driven Markets
Danzon, Patricia Munch, (2011)
-
Berndt, Ernst R., (2016)
- More ...
-
Understanding Contingencies Associated with the Early Adoption of Customer-Facing Web Portals
Baird, Aaron, (2012)
-
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement
Danzon, Patricia M., (2011)
-
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets
Danzon, Patricia M., (2011)
- More ...